Rythmol and Losartan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rythmol (propafenone hydrochloride) and Losartan (losartan potassium). Common drug interactions include haematoma among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Rythmol and Losartan. It is created by eHealthMe based on reports of 62 people who take the same drugs from the FDA, and is updated regularly.

What is Rythmol?

Rythmol has active ingredients of propafenone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 3,638 Rythmol users. Check the latest studies of Rythmol.

What is Losartan?

Losartan has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 177,695 Losartan users. Check the latest studies of Losartan.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Jul, 03, 2026

62 people who take Rythmol and Losartan together, and have interactions are studied.

Rythmol and Losartan drug interactions.

What are the common drug interactions of Rythmol and Losartan, by gender? *:

female:

  1. Haematoma (collection of blood outside the blood vessels)
  2. Haemorrhage (bleeding)
  3. Heart rate increased
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Idiopathic intracranial hypertension (elevated cerebrospinal fluid pressure of unknown cause)
  6. Ill-defined disorder
  7. Infarction (obstruction of the blood supply to an organ or region of tissue)
  8. Infection
  9. Injection site erythema (redness at injection site)
  10. Injection site hypertrophy (enlargement of an organ or tissue from the increase in size of its cells at injection site)

male:

  1. Diarrhoea
  2. Dizziness
  3. Abdominal discomfort
  4. Ageusia (loss of taste functions of the tongue)
  5. Balance disorder
  6. Blood glucose increased
  7. Constipation
  8. Decreased appetite
  9. Dehydration (dryness resulting from the removal of water)
  10. Diverticulum intestinal haemorrhagic (a pouch that is attached to the first part of the small intestine with bleeding)

What are the common drug interactions of Rythmol and Losartan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Benign intracranial hypertension (benign intracranial hypertension (bih) is a headache syndrome)
  2. Idiopathic intracranial hypertension (elevated cerebrospinal fluid pressure of unknown cause)

40-49:

  1. Chronic kidney disease
  2. Renal disorder (kidney disease)
  3. Renal failure (kidney dysfunction)
  4. Renal injury (kidney injury)

50-59:

  1. Injection site reaction
  2. Injection site swelling
  3. Injection site warmth
  4. Labyrinthitis (inflammation of the labyrinth or inner ear)
  5. Nasopharyngitis (inflammation of the nasopharynx)
  6. Nervousness
  7. Pain
  8. Skin exfoliation (removal of the oldest dead skin cells)
  9. Skin ulcer
  10. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)

60+:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Diarrhoea
  3. Cough
  4. Angina pectoris (chest pain due to ischemia of the heart muscle)
  5. Asthenia (weakness)
  6. Blood urine present
  7. Chest pain
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Drug ineffective
  10. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 9 people, 14.52%
  2. Immunodeficiency Common Variable: 8 people, 12.90%
  3. High Blood Cholesterol: 8 people, 12.90%
  4. Arrhythmias (irregular heartbeat): 8 people, 12.90%
  5. Multiple Myeloma (cancer of the plasma cells): 6 people, 9.68%
  6. Sleep Disorder: 5 people, 8.06%
  7. Psoriasis (immune-mediated disease that affects the skin): 5 people, 8.06%
  8. Cardiac Disorder: 5 people, 8.06%
  9. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Rythmol and Losartan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rythmol and Losartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rythmol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Losartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rythmol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Losartan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on propafenone hydrochloride and losartan potassium (the active ingredients of Rythmol and Losartan, respectively), and Rythmol and Losartan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: